Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8888 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(6-{[({amino[(4-chlorophenyl)amino]methylidene}amino)methanimidoyl]amino}hexyl)methanimidamide
CAS:Purity:99+%Molecular weight:505.45001226-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,9-dihydro-1H-purine-2-thione
CAS:Purity:96%Molecular weight:299.30999761-[(diaminomethylidene)amino]-N-(2-phenylethyl)methanimidamide
CAS:Purity:≥95%Molecular weight:205.2649994(2S)-2-amino-4-{[(diaminomethylidene)amino]oxy}butanoic acid; sulfuric acid
CAS:Purity:98%Molecular weight:274.25Sodium ((2R,3S,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl triphosphate
CAS:Purity:95%Molecular weight:556.0674-[(6-Diethylamino-pyrimidin-4-yl)-methyl-amino]-piperidine-1-carboxylic acid tert-butyl ester
CAS:Formula:C19H33N5O2Purity:95%Molecular weight:363.5064-(ethylsulfanyl)-2-hydrazinyl-6-methylpyrimidine
CAS:Formula:C7H12N4SPurity:95.0%Molecular weight:184.26ETHYL 6-CHLORO-2-(3-IODOPHENYL)PYRIMIDINE-4-CARBOXYLATE
CAS:Formula:C13H10ClIN2O2Purity:95.0%Molecular weight:388.59ETHYL 4-((3-CHLORO-4-METHOXYBENZYL)AMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLATE
CAS:Formula:C16H18ClN3O3SPurity:98%Molecular weight:367.85[1-(6-Ethoxy-pyrimidin-4-yl)-piperidin-3-yl]-methyl-carbamic acid tert-butyl ester
CAS:Formula:C17H28N4O3Purity:95%Molecular weight:336.436(E)-Methyl 2-(2-((6-chloropyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylate
CAS:Formula:C15H13ClN2O4Purity:97%Color and Shape:SolidMolecular weight:320.731-((2S,3R,4S,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
CAS:Formula:C10H13FN2O5Purity:97%Color and Shape:SolidMolecular weight:260.2214-Methoxy-6-methyl-N-(piperidin-4-yl)pyrimidin-2-amine dihydrochloride
CAS:Formula:C11H20Cl2N4OMolecular weight:295.21(2-Chloro-6-methyl-pyrimidin-4-yl)-ethyl-amine
CAS:Formula:C7H10ClN3Purity:95%Molecular weight:171.63Ethyl 2-cyclopropyl-6-oxo-1,6-dihydropyrimidine-5-carboxylate
CAS:Formula:C10H12N2O3Purity:95%Molecular weight:208.2172,5,6-Triaminopyrimidin-4-yl hydrogen sulfate
CAS:Formula:C4H7N5O4SPurity:95%+Molecular weight:221.19{2-[4-methyl-6-(trifluoromethyl)-2-pyrimidinyl]ethyl}amine hydrochloride
CAS:Formula:C8H11ClF3N3Purity:95.0%Molecular weight:241.64Methyl 6-chloro-2-(methylsulfonyl)pyrimidine-4-carboxylate
CAS:Formula:C7H7ClN2O4SPurity:98%Color and Shape:SolidMolecular weight:250.651-[6-(Aminomethyl)pyrimidin-4-yl]piperidin-2-one trihydrochloride
Formula:C10H17Cl3N4OMolecular weight:315.62N-(6-Chloro-7H-purin-2-yl)acetamide
CAS:Formula:C7H6ClN5OPurity:97%Color and Shape:SolidMolecular weight:211.617-allyl-8-amino-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
CAS:Formula:C10H13N5O2Purity:95.0%Molecular weight:235.247(2-AMINO-4,6-DICHLOROPYRIMIDIN-5-YL)METHANOL
CAS:Formula:C5H5Cl2N3OPurity:95.0%Molecular weight:194.022-Chloro-4-hydrazinopyrimidine
CAS:Formula:C4H5ClN4Purity:>95%Color and Shape:SolidMolecular weight:144.561-(2-Fluorophenyl)-3-(piperidin-4-yl)urea hydrochloride
CAS:Formula:C12H17ClFN3OPurity:95.0%Molecular weight:273.744-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
CAS:Formula:C21H16F3N3O3Purity:97%Molecular weight:415.372ETHYL 2-ETHYLPYRIMIDINE-5-CARBOXYLATE
CAS:Formula:C9H12N2O2Purity:95.0%Color and Shape:LiquidMolecular weight:180.207N4,N4-dimethyl-N6-(piperidin-4-yl)pyrimidine-4,6-diamine
CAS:Formula:C11H19N5Purity:95.0%Molecular weight:221.3084-bromo-1-(pyrimidin-2-yl)-1H-pyrazol-3-amine
CAS:Formula:C7H6BrN5Purity:95.0%Molecular weight:240.0642,4,6-Trichloro-5-cyanopyrimidine
CAS:Formula:C5Cl3N3Purity:97%Color and Shape:SolidMolecular weight:208.438-13C-Uric Acid (contains ~1.5% unlabelled)
CAS:Controlled Product<p>Applications 8-13C-Uric Acid is the labeled analogue of Uric Acid (U829200), a heterocyclcic compound that is created when purine nucleotides are broken down of by the human body. High blood concetration of Uric Acid is known as hyperuricemia and is often associated with a wide range of disorders and medical conditions such as gout, diabetes and metabolic syndrome. Uric acid may be a marker of oxidative stress and may have a potential therapeutic role as an antioxidant.<br>References Heinig, M. et al.: Cle. Clin. J. Med., 73, 1059 (2006); Glantzounis, G.K. et al.: Curr. Pharmac. Des., 11, 4145 (2005); Dehghan, A. et al.: Diab. Care, 31, 361 (2008); Nakagawa, T. et al.: Am. J. Physiol. Renal Physiol., 290, F625 (2006)<br></p>Formula:C413CH4N4O3Color and Shape:NeatMolecular weight:169.1Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications Tenofovir is an acyclic phosphonate nucleotide analogue and reverse transcriptase inhibitor. It is used as an anti-HIV agent. Antiviral. Tenofovir (T018500) impurity.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997); Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007);<br></p>Formula:C20H33N6O9PColor and Shape:NeatMolecular weight:532.48Oseltamivir Acid Methyl Ester Phosphate Salt
CAS:<p>Applications An impurity of the antiviral drug Oseltamivir (O700100). It is a COVID19-related research product.<br></p>Formula:C15H29N2O8PColor and Shape:NeatMolecular weight:396.375-Amino-4-pyrazolecarboxamide
CAS:Controlled ProductFormula:C4H6N4OColor and Shape:Off White To Light BrownMolecular weight:126.117Methotrexate Tetraglutamate Trifluoroacetate
CAS:Controlled Product<p>Applications Methotrexate Tetraglutamate is a metabolite of Methotrexate (M260675); a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C35H43N11O14xC2HF3O2Color and Shape:NeatMolecular weight:841.78rac-Clopidogrel Carboxylic Acid Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications rac-Clopidogrel Carboxylic Acid Hydrochloride is a salt metabolite of rac-Clopidogrel.<br></p>Formula:C15H15Cl2NO2SColor and Shape:NeatMolecular weight:344.261-(6-Amino-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
CAS:Controlled ProductFormula:C10H10N8OColor and Shape:NeatMolecular weight:258.24Urea-d4
CAS:Controlled Product<p>Applications Labelled Urea. Physiological regulator of nitrogen excretion in mammals; synthesized in the liver as an end-product of protein catabolism and excreted in urine. Also occurs normally in skin. Emollient; diuretic.<br>References Demetriou, A., et al.: Science, 233, 1190 (1986), Aebischer, P., et al.: Nat. Med., 2, 696 (1996), Prakash, S., et al.: Biotechnol. Bioeng., 46, 621 (1995),<br></p>Formula:CD4N2OColor and Shape:NeatMolecular weight:64.082-Oxo Clopidogrel-13C,d3 Hydrochloride(Mixture of Diastereomers)
CAS:Controlled ProductFormula:C1513CH14D3Cl2NO3SColor and Shape:NeatMolecular weight:378.292-Chloro-6-amino-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine
CAS:Controlled Product<p>Applications 2-Chloro-6-amino-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine (cas# 79999-39-6) is a compound useful in organic synthesis.<br></p>Formula:C16H18ClN5O7Color and Shape:NeatMolecular weight:427.80Valbenazine (~90% Purity)
CAS:Controlled Product<p>Applications Valbenzine is a highly selective vesicular monoamine transporter 2 inhibitor. It is used in the treatment of tardive dykinesia.<br>References O'Brien, C. et al.: Movement Dis., 30, 1681 (2015);<br></p>Formula:C24H38N2O4Purity:~90%Color and Shape:NeatMolecular weight:418.57N-(5-Aminopentyl) Methotrexate Amide
CAS:Controlled Product<p>Applications The 5-aminopentyl amide derivative of the folic acid antagonist Methotrexate (M260675) used in the study of membrane-associated folate transporters from L1210 cells.<br>References Fan, J. et al.: J. Biol. Chem., 266, 14862 (1991);<br></p>Formula:C25H34N10O4Color and Shape:NeatMolecular weight:538.6Chloroformic Acid Chloromethyl Ester
CAS:Controlled Product<p>Stability Very Very Moisture sensitive<br>Applications Chloroformic Acid Chloromethyl Ester is used as a reagent in the synthesis of carbamates and carbonates.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Safadi, M. et al.: Pharm. Res. 10, 1350 (1993); Loren, J.C. et al.: Synlett, 18, 2847 (2005);<br></p>Formula:C2H2Cl2O2Color and Shape:Colourless OilyMolecular weight:128.942-Pyrimidinemethanamine
CAS:Controlled Product<p>Applications 2-Pyrimidinemethanamine (cas# 75985-45-4) is a useful research chemical.<br></p>Formula:C5H7N3Color and Shape:NeatMolecular weight:109.132,4-Diamino-6-(hydroxymethyl)pteridine Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Methotrexate intermediate.<br>References Feng, Y., et al.: J. Med. Chem., 49, 770 (2006),<br></p>Formula:C7H8N6O·ClHColor and Shape:YellowMolecular weight:228.64Methotrexate Hexaglutamate Trifluoroacetate
CAS:<p>Stability Hygroscopic<br>Applications Methotrexate Hexaglutamate is a metabolite of Methotrexate (M260675); a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C45H57N13O20·x(C2HF3O2)Color and Shape:Yellow SolidMolecular weight:1214.03N-Sulfamoylethyl Naratriptan Pyridinium Chloride
CAS:Controlled Product<p>Impurity Naratriptan Impurity F<br>Stability Hygroscopic<br>Applications 4-[1,5-Bis-(2-methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium Chloride is an impurity of Naratriptan (N378730).<br></p>Formula:C20H27ClN4O4S2Color and Shape:NeatMolecular weight:487.04Methotrexate-d3 Pentaglutamate Trifluoroacetate (>90%)
CAS:Controlled Product<p>Applications Methotrexate-d3 Pentaglutamate is the isotope labelled analog of Methotrexate Pentaglutamate (M260735); a metabolite of Methotrexate (M260675) which is a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C40H47D3N12O17(C2HF3O2)xColor and Shape:NeatMolecular weight:973.91Sumatriptan Hydroxy-Oxindole Impurity (Sumatriptan Impurity 1)
CAS:Controlled Product<p>Applications Sumatriptan Impurity 1, is an impurity of Sumatriptan (S810000), which is a serotonin 5HT1-receptor agonist, used for the treatment of migraine headaches.<br>References Humphrey, P.P.A., et al.: Brit. J. Pharmacol., 94, 1123 (1988), Doenicke, A., et al.: Lancet 1, 1309 (1988),<br></p>Formula:C14H21N3O4SColor and Shape:NeatMolecular weight:327.4m-Hydroxyhippuric Acid-13C2, 15N
CAS:<p>Applications m-Hydroxyhippuric Acid-13C2, 15N is labelled m-Hydroxyhippuric Acid (H943125) which is a metabolite of caffeic and chlorogenic acids in human.<br>References Booth, A., et al.: J. Biol. Chem., 229, 51 (1957); Gonthier, M., et al.: Biomed. Pharmacother., 60, 536 (2006)<br></p>Formula:C713C2H915NO4Color and Shape:White To Off-WhiteMolecular weight:198.15Almotriptan-d6 Hydrochloride
CAS:Controlled Product<p>Applications: Labelled Almotriptan (A575200). Almotriptan is a serotonin 5HT1B /1D-receptor agonist used for treatment of migraine.<br>References Fleishaker, J.C., et al.: Clin. Pharmacol. Ther., 67, 498 (2000), Kamali, F., et al.: Curr. Opin. Cent. Peripher. Nerv. Syst. Invest. Drugs, 2, 197 (2000), Dodick, D.W., et al.: Expert Opin.Pharmacother., 4, 1157 (2003)<br></p>Formula:C172H6H19N3O2S·ClHColor and Shape:NeatMolecular weight:377.96N10-Monodesmethyl Rizatriptan
CAS:Controlled Product<p>Impurity Rizatriptan EP Impurity I<br>Applications N10-Monodesmethyl Rizatriptan (Rizatriptan EP Impurity I) is a metabolite of Rizatriptan.<br>References Dechant, K., et al.: Drugs, 43, 776 (1992), Castro, J., et al.: Bioorg. Med. Chem. Lett., 3, 993 (1993), Lee, Y., et al.: Biopharm. Drug Dispos., 19, 577 (1998), Chen, J., et al.: J. Pharm. Biomed. Anal., 35, 639 (2004),<br></p>Formula:C14H17N5Color and Shape:NeatMolecular weight:255.32Pemetrexed Disodium Heptahydrate
CAS:Controlled Product<p>Applications Pemetrexed Disodium Heptahydrate is an chemotherapy drug for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed Disodium Heptahydrate exhibit inhibitory activities towards thymidylate synthase as well as other folate dependent enzymes.<br>References Vogelzang, N.J., et al.: J. Clin. Oncol., 21,2636 (2003); Paz-Ares, L., et al.: Lancet. Oncol., 13, 247 (2012);<br></p>Formula:C20H19N5O6·2Na·7H2OColor and Shape:NeatMolecular weight:597.48(N,N-Dimethyl-1-butanamine) Zolmitriptan Dimer
CAS:Controlled Product<p>Impurity Zolmitriptan USP Related Compound F<br>Stability Hygroscopic<br>Applications (N,N-Dimethyl-1-butanamine) Zolmitriptan Dimer (Zolmitriptan USP Related Compound F) is an impurity from the synthesis of Zolmitriptan (Z639000). Zolmitriptan is a Serotonin 5HTID-receptor agonist.<br>References Glen, R.C., et al.: J. Med. Chem., 38, 3566 (1995), Seaber, E., et al.: Brit. J. Clin. Pharmacol., 41, 141 (1996), Tepper, S.J., et al.: Curr. Med. Res. Opin., 15, 254 (1999)<br></p>Formula:C38H53N7O4Purity:>90%Color and Shape:NeatMolecular weight:671.871-(3-(2-(Dimethylamino)ethyl)-1-((5-((N-methylsulfamoyl)methyl)-1H-indol-3-yl)methyl)-1H-indol-5-yl)-N-methylmethanesulfonamide Formate Salt
CAS:Controlled ProductFormula:C25H33N5O4S2·CH2O2Color and Shape:NeatMolecular weight:531.6946036-Oxo-(S,S)-Palonosetron (~90%)
CAS:Controlled Product<p>Applications 6-Oxo-(S,S)-Palonosetron is an impurity of (S,S)-Palonosetron (P165800), a serotonin 5-HT3 receptor antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). Antiemetic.<br>References Clark, R.D., et al.: J. Med. Chem., 36, 2645 (1993), Wong, E.H.F., et al.: Br. J. Pharmacol., 114, 851 (1995), Grunberg, S.M., et al.: Expert. Opin. Pharmacother., 4, 2297 (2003), Eisenberg, P., et al.: Ann. Oncol., 15, 330 (2004), Siddiqui, M.A.A., et al.: Drugs, 64, 1125 (2004),<br></p>Formula:C19H22N2O2Purity:~90%Color and Shape:NeatMolecular weight:310.39Ethyl 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylate
Controlled Product<p>Applications Ethyl 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylate, is an impurity in the synthesis of Febuxostat n-Butyl Isomer (F229035).<br></p>Formula:C18H20N2O3SColor and Shape:NeatMolecular weight:344.434-Hydroxy-1,3-benzenedicarbonitrile
CAS:Controlled Product<p>Applications 4-Hydroxy-1,3-benzenedicarbonitrile is used in the preparation of febuxostat (F229000), a non-purine xanthine oxidase inhibitor used as a treatment for hyperuricaemia and chronic gout.<br>References Smith, C.J., et al.: Bioorg. Med. Chem. Lett., 20, 346 (2010); Cramp. S., et al.: BIoorg. Med. Chem. Lett., 20, 2516 (2010); Sato, T., et al.: Bioorg. Med. Chem. Lett., 19, 184 (2009);<br></p>Formula:C8H4N2OColor and Shape:NeatMolecular weight:144.13Diethyl p-Toluenesulfonyloxymethylphosphonate
CAS:Controlled Product<p>Applications Diethyl p-Toluenesulfonyloxymethylphosphonate is an antiviral agent and a Tenofovir (T018500) intermediate. Tenofovir is an acyclic phosphonate nucleotide analogue and reverse transcriptase inhibitor used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>Formula:C12H19O6PSColor and Shape:NeatMolecular weight:322.31Tenofovir (1 mg/mL in Water)
CAS:Formula:C9H14N5O4PColor and Shape:Single SolutionMolecular weight:287.21rac-Clopidogrel Hydrogen Sulfate
CAS:Controlled Product<p>Applications rac-Clopidogrel Hydrogen Sulfate is used in the synthesis of Clopidogrel derivatives as platelet aggregation inhibitors.<br>References Chen, J., et. al.: Hecheng Huaxue, 18, 586 (2010); Defreyn, G. et al.: Thromb. Haemo., 65, 186 (1991);<br></p>Formula:C16H16ClNO2S·H2O4SColor and Shape:Off-WhiteMolecular weight:419.90Sumatriptan N-Oxide
CAS:Controlled Product<p>Impurity Sumatriptan EP Impurity D<br>Stability Hygroscopic, Unstable in DMSO<br>Applications Sumatriptan N-Oxide (Sumatriptan EP Impurity D) is the degradation product of the antimigraine drug Sumatriptan (S810000).<br>References Xu, X. et al.: J. Pharmac. Biomed. Anal., 26, 367 (2001); Cheng, K.N. et al.: J. Pharmac. Biomed. Anal., 17, 399 (1998);<br></p>Formula:C14H21N3O3SColor and Shape:Light Beige To Light BrownMolecular weight:311.40[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester
CAS:Controlled Product<p>Applications [[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester is an antiviral agent and a Tenofovir (T018500) intermediate. Tenofovir is an acyclic phosphonate nucleotide analogue and reverse transcriptase inhibitor, used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997); Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005); Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006); Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007);<br></p>Formula:C15H18N5O4PColor and Shape:NeatMolecular weight:363.31p-Chlorophenylcyanoguanidine
CAS:Controlled Product<p>Impurity Proguanil USP Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine)<br>Applications Halo-aryl substituted guanidine derivative used in the preparation of antimalarial agents. Proguanil USP Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine).<br>References Warner, V. et al.: J. Pharmac. Sci., 66, 418 (1977); Das, A. et al.: Ind. Drugs, 20, 19 (1980);<br></p>Formula:C8H7ClN4Color and Shape:NeatMolecular weight:194.62Caffeidine Acid
CAS:Controlled Product<p>Applications Caffeidine Acid is a degradation compound of Caffeine (C080100), which is a central nervous system stimulant.<br>References Kigasawa, K., et al.: Chem. Pharm. Bull., 22, 2448 (1974); Peinhardt, G.: Pharmazie, 46, 812 (1991); Kumar, R., et al.: Carcinogenesis, 13, 2179 (1992);<br></p>Formula:C8H12N4O3Color and Shape:NeatMolecular weight:212.21Methotrexate-d3 (Technical Grade) (100ug/mL in Methanol with 1% 0.1N NaOH)
CAS:Controlled ProductFormula:C20H19D3N8O5Color and Shape:Single SolutionMolecular weight:457.46Tenofovir Dimer Triethylammonium Salt
CAS:Controlled Product<p>Stability Very Hygroscopic<br>Applications Tenofovir Dimer is a dimer of Tenofovir (T018500). Tenofovir is a reverse transcriptase inhibitor. Used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>Formula:C30H56N12O7P2Color and Shape:NeatMolecular weight:758.79(S)-9-[2-(Hydroxypropyl] Adenine
CAS:<p>Applications (S)-9-[2-(Hydroxypropyl] Adenine is an inhibitor of adenosine deaminase. (S)-9-[2-(Hydroxypropyl] Adenine is used in the preparation of antiviral acyclic nucleoside thiophosphonates such as (S)-Tenofovir Disoproxil Fumarate (T018506).<br>References Roux, L. et al.: Eur. J. Med. Chem., 63, 869 (2013); Schaeffer, H. et al.: J. Med. Chem., 15, 456 (1972); Schaeffer, H. & Vince, R.: J. Med. Chem., 10, 689 (1967)<br></p>Formula:C8H11N5OColor and Shape:Off White SolidMolecular weight:193.206Descarboxyl Febuxostat
CAS:Controlled ProductFormula:C15H16N2OSColor and Shape:NeatMolecular weight:272.373-Descyano Febuxostat Ethyl Ester
CAS:Controlled Product<p>Applications 3-Descyano Febuxostat Ethyl Ester is an impurity of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.<br>References Vallu, V., et. al.: Anal. Chem. Indian J., 14, 339 (2014); Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993); Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003); Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005); Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005)<br></p>Formula:C17H21NO3SColor and Shape:NeatMolecular weight:319.42Lestaurtinib
CAS:Controlled Product<p>Stability Photosensitive<br>Applications It is used for the treatment of pancreatic cancer and acute myelogenous leukaemia (AML).<br></p>Formula:C26H21N3O4Color and Shape:NeatMolecular weight:439.465-Aminoimidazole-4-carboxamide-15N2 Hydrochloride (>90%)
CAS:Controlled ProductFormula:C4H7ClN215N2OPurity:>90%Color and Shape:NeatMolecular weight:164.56cis (2,3)-Dihydro Tetrabenazine
CAS:Controlled Product<p>Applications A metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis isomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),<br></p>Formula:C19H29NO3Color and Shape:NeatMolecular weight:319.441-Methyl-1,4-dihydronicotinamide
CAS:Controlled Product<p>Stability Light Sensitive, Temperature Sensitive<br>Applications 1-Methyl-1,4-dihydronicotinamide (cas# 17750-23-1) is a compound useful in organic synthesis.<br></p>Formula:C7H10N2OColor and Shape:NeatMolecular weight:138.17Picolinamide
CAS:Controlled Product<p>Applications A nicotinic acid derivative for prevention and treatment of cancer by activating RUNX3 gene.<br>References Ludwig, et al.: Cancer Res., 50, 2470 (1990), Gupta., et al.: Biomed. Environ. Sci., 13,122 (2000), Cai., et al.: J. Med. Chem., 46, 2474 (2003),<br></p>Formula:C6H6N2OColor and Shape:NeatMolecular weight:122.12Febuxostat 67M-2
CAS:Controlled Product<p>Applications Febuxostat 67M-2 is a derivative compound of Febuxostat 67M-1 (F229005) which is an inhibitor of xanthine oxidase. It reduces uric acid production in the body and also used to reduce the risk of gout or kidney stone formation.<br>References Du, J., et al.: Handbook of Metabolic Pathways of Xenobiotics, 4, 1395 (2014)<br></p>Formula:C16H16N2O4SColor and Shape:NeatMolecular weight:332.37Mono-POC Tenofovir 6-Isopropyl Carbamate (Mixture of Diastereomers)
CAS:Controlled Product<p>Stability Very Hygroscopic<br>Applications Tenofovir (T018500) impurity.<br></p>Formula:C18H28N5O9PColor and Shape:White SolidMolecular weight:489.42
![1-({amino[(4-chlorophenyl)amino]methylidene}amino)-N-(6-{[({amino[(4-chlorophenyl)amino]methyliden…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF868772.webp&w=3840&q=75)
![6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,9-dihydro-1H-purine-2-thione](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF615204.webp&w=3840&q=75)
![1-[(diaminomethylidene)amino]-N-(2-phenylethyl)methanimidamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF830530.webp&w=3840&q=75)
![(2S)-2-amino-4-{[(diaminomethylidene)amino]oxy}butanoic acid; sulfuric acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF826884.webp&w=3840&q=75)
![4-[(6-Diethylamino-pyrimidin-4-yl)-methyl-amino]-piperidine-1-carboxylic acid tert-butyl ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF090963.webp&w=3840&q=75)
![[1-(6-Ethoxy-pyrimidin-4-yl)-piperidin-3-yl]-methyl-carbamic acid tert-butyl ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF088917.webp&w=3840&q=75)
![{2-[4-methyl-6-(trifluoromethyl)-2-pyrimidinyl]ethyl}amine hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF359092.webp&w=3840&q=75)
![1-[6-(Aminomethyl)pyrimidin-4-yl]piperidin-2-one trihydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF550020.webp&w=3840&q=75)
![4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF547024.webp&w=3840&q=75)
![[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA628898.webp&w=3840&q=75)
![(S)-9-[2-(Hydroxypropyl] Adenine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH952690.webp&w=3840&q=75)
